The session will present and discuss abstracts on a range of lung disease in cystic fibrosis. The topics covered will include chronic lung changes in minimally symptomatic children, management of new pathogens, management of exacerbations, the impact of CFTR modulators on lung function, and outcomes associated with severe lung disease in adult patients.
Examine the impact of CFTR modulators on lung function and structure in Cystic Fibrosis.
Assess the impact of advanced lung disease on survival in adult cystic fibrosis patients.
Analyze the impact of outpatient management of pulmonary exacerbations on lung function.